Fundz

Fundz Deep Dive

Everything you need to win Selecta Biosciences — in one platform.

Who to reach, what to say, and why now on Selecta Biosciences — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Selecta Biosciences — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing

Jul 02, 2024•almost 2 years ago

Contract Type

partnership

FrederickBiotechnologyHealth CareTherapeuticsBiopharma

Description

Cartesian Therapeutics, Inc. has entered into a securities purchase agreement for a private investment in public equity (“PIPE”) financing that is expected to result in gross proceeds of approximately $130.0 million to the Company. The financing included participation from both new and existing investors, including HBM Healthcare Investments (Cayman) Ltd., Invus, Schooner Capital, Surveyor Capital, Timothy A. Springer, Ph.D., and other institutional investors.

Company Information

Company

Selecta Biosciences

Location

704 Quince Ochard Road

Frederick, Maryland, United States

About

Selecta Biosciences is a biotechnology company focused on modulating the immune system to enhance the efficacy of gene-based therapies. Its core technology, ImmTOR, aims to induce immune tolerance to reduce unwanted responses. The company engages in research collaborations, leveraging its innovative approaches to address autoimmune diseases and rare conditions.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Selecta Biosciences's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.